<DOC>
	<DOCNO>NCT02352662</DOCNO>
	<brief_summary>This prospective study aim globally assess coagulopathy induce cardiac surgery cardiopulmonary bypass ( CPB ) large pediatric population . The investigator primary objective understanding CPB-induced coagulopathy base demographic surgical characteristic , coagulation assay . Secondary objective aim determine relationship coagulation assay , postoperative blood loss , transfusion requirement . The ultimate goal design algorithm use point-of-care monitoring could use guide hemostatic therapy neonates child undergo cardiac surgery.To , investigator examine coagulation laboratory base setting .</brief_summary>
	<brief_title>Peri-operative Assessment Coagulopathy Neonates Infants Undergoing Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Neonates weigh great 2.5 kg Patients equal less 12 month age Undergoing elective cardiac surgery cardiopulmonary bypass Emergent procedure The patient deem moribund condition ( American Society Anesthesiology ( ASA 5 ) )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Congenital Heart Disease</keyword>
	<keyword>Point-of-care coagulation monitoring</keyword>
	<keyword>Rotaional Thromboelastometry</keyword>
</DOC>